San Francisco area Event report • Committees
Women leading change in Life Sciences and Healthcare
Join us for an engaging panel with women trailblazing in the infectious disease field, from research to patient care!
In a field where scientific breakthroughs often define the headlines, this evening placed the spotlight elsewhere: on the people driving those breakthroughs forward.
Co-hosted by our Healthcare and Life Sciences Committee and the Women Leadership Committee, the panel “Women Leading Change in Life Sciences and Healthcare” brought together leading voices in infectious diseases research, clinical practice, and biotech innovation for an evening of exchange, reflection, and inspiration.
The discussion opened a broader narrative beyond science alone: how personal trajectories - across countries, cultures, and disciplines - shape the way research and healthcare are approached today. From Mexico to Germany to India, and across leading institutions in the United States, the panelists illustrated how global experiences directly inform scientific impact, particularly in fields as critical as infectious diseases.
The panel featured distinguished experts:
- Ritu Lal, CEO and Co-Founder of GEn1E Lifesciences Inc.
- Yvonne Maldonado, Taube Professor of Global Health and Infectious Diseases and Senior Associate Dean for Faculty Development and Diversity at Stanford University School of Medicine.
- Melanie Ott, director and a sr. investigator at the Gladstone Institute of Virology, SVP of Gladstone and Professor of medicine at the University of California San Francisco.
- Moderated by Cassy Christianson, MA, OTR, therapist in pediatrics and maternal health, Vice-Chair and incoming Chair of Stanford Medicine Community Council.
Each speaker shared not only their scientific expertise, but also the personal and professional paths that led them into life sciences leadership. A powerful thread throughout the evening was the connection between identity, experience, and scientific direction.
- Dr. Yvonne Maldonado reflected on how her Mexican origins shaped her commitment to child health, vaccines, and early detection strategies in infectious disease prevention.
- Dr. Ritu Lal shared her journey from India to Silicon Valley, her passion for pharmacology, and her transition from working in pharmaceutical organizations to founding a biotech startup, describing the evolution into what she called a “pharmapreneur.”
- Dr. Melanie Ott traced her path from Germany to the Bay Area, highlighting how the AIDS epidemic deeply influenced her focus on virology, research leadership, and the challenges and opportunities of running a scientific laboratory within the Silicon Valley ecosystem.
Across these stories, a shared theme emerged: scientific leadership is not linear—it is built through experience, adaptation, and persistence across multiple worlds.
The conversation also underscored the continued urgency of infectious disease research in a changing global context. From prevention and early detection to vaccine development and translational research, the panel emphasized the importance of multidisciplinary approaches to addressing both longstanding and emerging public health threats. The Bay Area ecosystem was repeatedly highlighted as a unique environment where academia, biotech, and innovation intersect to accelerate impact.
All in all, the conversation went beyond technical expertise to explore leadership, resilience, and the human dimension of scientific progress. It offered a powerful reminder that breakthroughs in medicine are not only driven by research, but also by the individuals whose journeys shape the questions being asked.
